Research progress of detection of lymph node metastases by 68Ga-PSMA PET in prostate cancer patients
10.3760/cma.j.cn112330-20220513-00284
- VernacularTitle:68Ga-PSMA PET检查诊断前列腺癌患者淋巴结转移的研究进展
- Author:
Jianhua JIAO
1
;
Yuming JING
;
Jian CHEN
;
Wenhui YANG
;
Qin XUE
;
Weijun QIN
Author Information
1. 空军军医大学第一附属医院泌尿外科，西安 710032
- Keywords:
Prostatic neoplasms;
Carcinoma;
Lymph node metastases;
Prostate specific membrane antigen;
Positron emission tomography
- From:
Chinese Journal of Urology
2022;43(7):552-554
- CountryChina
- Language:Chinese
-
Abstract:
With wide application of 68Ga-prostate specific membrane antigen(PSMA)positron emission tomography(PET)technology in the diagnosis of prostate cancer (PCa), researchers have paid more attention to nodal staging in PCa by 68Ga-PSMA PET. Currently, 68Ga-PSMA PET has been used to detect lymph node metastases (LNMs) in primary prostate cancer patients and recurrent prostate cancer patients. Compared with the traditional imaging techniques, 68Ga-PSMA PET can detect LNMs with higher sensitivity, specificity and accuracy, which has great impact on treatment management of PCa patients. This article reviewed the research progress of detection of LNMs by 68Ga-PSMA PET in prostate cancer patients.
